Physician profile
Yee Lee
NPI 1346024767
$2,394.74
in general payments reported to CMS, 2019-2025
15 companies · $2,395 in 2025
The $2,395 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,394.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $709.00 | 2025 | |
| Madrigal Pharmaceuticals | $433.84 | 2025 | Rezdiffra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $260.79 | 2025 | Xifaxan |
| Ardelyx, INC. | $252.28 | 2025 | Ibsrela |
| Genzyme Corporation | $150.00 | 2025 | |
| Janssen Biotech, INC. | $125.47 | 2025 | Tremfya |
| Ipsen Biopharmaceuticals, INC | $121.84 | 2025 | Iqirvo |
| Gilead Sciences, INC. | $92.36 | 2025 | |
| Orphalan INC | $60.74 | 2025 | Cuvrior |
| Phathom Pharmaceuticals, INC. | $44.29 | 2025 | Voquezna |
| Pfizer INC. | $40.24 | 2025 | |
| Tempus Ai, INC | $28.99 | 2025 | Xt Cdx |
| Qol Medical, LLC | $27.50 | 2025 | Sucraid |
| Lilly USA, LLC | $24.69 | 2025 | Omvoh |
| Novo Nordisk INC | $22.71 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yee Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.